by Julie Telgenhoff
Smallpox as a weapon in America can be traced back to Lord Jeffrey Amherst, commander of British forces in North America during the French and Indian War (1756-1763) during the Pontiac Rebellion which broke out after the war. Amherst first positioned the opportunity of giving the American Indians infected blankets in a letter to Colonel Henry Bouquet who would later lead reinforcements to Fort Pitt.
Bouquet discussed the letter in a postscript dated July 13, 1763:
“I will try to inoculate the Indians by means of Blankets that may fall in their hands….”
To which Amherst replied:
“You will do well to inoculate the Indians by means of blankets…as to try every other method that can serve to extirpate this execrable race…”
History does not know if Bouquet actually followed through with the plan, however, several other letters from the summer of 1763 show the smallpox idea was not an anomaly. The letters are filled with comments that indicate a genocidal intent via germ warfare.
You can see the original writings here.
So one might ask the reader if it would seem possible for this same type of germ warfare to be created and utilized against governmental populations in the 21st century???
Could the FDA and it’s Big Pharma buddies be forewarning us of an upcoming smallpox epidemic to which the government created and therefore, as usual with false flag operations, they already have the planned solution in place (TPOXX)???
The Food and Drug Administration has approved the first drug for treating smallpox, a response to experts’ fears that the virus could be used as a bioweapon.
TPOXX, or tecovirimat, is taken orally to treat smallpox “to mitigate the impact of a potential outbreak,” pharmaceutical company SIGA Technologies said in a statement.
The World Health Organization declared smallpox eradicated in 1980, and vaccination for Americans against the virus was stopped, according to the Centers for Disease Control and Prevention.
The approval of the drug addresses concerns the smallpox virus could be used in biological warfare.
“This new treatment affords us an additional option should smallpox ever be used as a bioweapon,” FDA Commissioner Scott Gottlieb, M.D, said in a statement.
There exists “no immediate, direct threat of a bioterrorist attack using smallpox,” according to the CDC.
Researchers tested the drug’s effectiveness against smallpox through studies involving animals infected with the virus. The drug was also tested with human volunteers not infected with smallpox.
Headache, nausea, and abdominal pain remained the commonly reported side effects.
The virus spread largely through direct contact with people, said the FDA. Symptoms usually appeared 10 to 14 days after infection. They included fever, exhaustion, headache and backache, as well as a rash initially consisting of small, pink bumps progressing to pus-filled sores.